Sudden cardiac death

New approaches for implantable cardioverter-defibrillators (ICDs)

Riccardo Cappato, Hussam Ali

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The implantable cardioverter-defibrillator (ICD) has shown its superiority to anti-arrhythmic drugs in the prevention of sudden cardiac death. However, the conventional transvenous ICDs are still associated with substantial risks and comorbidities mainly related to the transvenous leads. The recent advent of an entirely sub-cutaneous ICD (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. Clinical data are growing regarding the safety and efficacy of S-ICD in prevention of sudden cardiac death in selected patients without pacing indications. This novel technology seems promising and particularly beneficial in young patients with channelopathies, conditions at high risk of infection, or in those who experienced previous complications related to the transvenous leads. The S-ICD technology is still developing regarding the device, diagnostic capabilities, and the surgical implantation technique. Further advancements and potential integration with the leadless pacing technology may realize an outstanding evolution in defibrillation therapy and prevention of sudden cardiac death in the near future.

Original languageEnglish
Pages (from-to)38-41
Number of pages4
JournalInternational Journal of Cardiology
Volume237
DOIs
Publication statusPublished - Jun 15 2017

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Technology
Skin
Channelopathies
Anti-Arrhythmia Agents
Comorbidity
Safety
Equipment and Supplies
Infection
Pharmaceutical Preparations
Therapeutics

Keywords

  • Defibrillation technology
  • Subcutaneous ICD
  • Sudden cardiac death
  • Ventricular arrhythmias

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sudden cardiac death : New approaches for implantable cardioverter-defibrillators (ICDs). / Cappato, Riccardo; Ali, Hussam.

In: International Journal of Cardiology, Vol. 237, 15.06.2017, p. 38-41.

Research output: Contribution to journalArticle

@article{04d24b99cb9e4d148f6cd788a5bef16c,
title = "Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs)",
abstract = "The implantable cardioverter-defibrillator (ICD) has shown its superiority to anti-arrhythmic drugs in the prevention of sudden cardiac death. However, the conventional transvenous ICDs are still associated with substantial risks and comorbidities mainly related to the transvenous leads. The recent advent of an entirely sub-cutaneous ICD (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. Clinical data are growing regarding the safety and efficacy of S-ICD in prevention of sudden cardiac death in selected patients without pacing indications. This novel technology seems promising and particularly beneficial in young patients with channelopathies, conditions at high risk of infection, or in those who experienced previous complications related to the transvenous leads. The S-ICD technology is still developing regarding the device, diagnostic capabilities, and the surgical implantation technique. Further advancements and potential integration with the leadless pacing technology may realize an outstanding evolution in defibrillation therapy and prevention of sudden cardiac death in the near future.",
keywords = "Defibrillation technology, Subcutaneous ICD, Sudden cardiac death, Ventricular arrhythmias",
author = "Riccardo Cappato and Hussam Ali",
year = "2017",
month = "6",
day = "15",
doi = "10.1016/j.ijcard.2017.03.064",
language = "English",
volume = "237",
pages = "38--41",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Sudden cardiac death

T2 - New approaches for implantable cardioverter-defibrillators (ICDs)

AU - Cappato, Riccardo

AU - Ali, Hussam

PY - 2017/6/15

Y1 - 2017/6/15

N2 - The implantable cardioverter-defibrillator (ICD) has shown its superiority to anti-arrhythmic drugs in the prevention of sudden cardiac death. However, the conventional transvenous ICDs are still associated with substantial risks and comorbidities mainly related to the transvenous leads. The recent advent of an entirely sub-cutaneous ICD (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. Clinical data are growing regarding the safety and efficacy of S-ICD in prevention of sudden cardiac death in selected patients without pacing indications. This novel technology seems promising and particularly beneficial in young patients with channelopathies, conditions at high risk of infection, or in those who experienced previous complications related to the transvenous leads. The S-ICD technology is still developing regarding the device, diagnostic capabilities, and the surgical implantation technique. Further advancements and potential integration with the leadless pacing technology may realize an outstanding evolution in defibrillation therapy and prevention of sudden cardiac death in the near future.

AB - The implantable cardioverter-defibrillator (ICD) has shown its superiority to anti-arrhythmic drugs in the prevention of sudden cardiac death. However, the conventional transvenous ICDs are still associated with substantial risks and comorbidities mainly related to the transvenous leads. The recent advent of an entirely sub-cutaneous ICD (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. Clinical data are growing regarding the safety and efficacy of S-ICD in prevention of sudden cardiac death in selected patients without pacing indications. This novel technology seems promising and particularly beneficial in young patients with channelopathies, conditions at high risk of infection, or in those who experienced previous complications related to the transvenous leads. The S-ICD technology is still developing regarding the device, diagnostic capabilities, and the surgical implantation technique. Further advancements and potential integration with the leadless pacing technology may realize an outstanding evolution in defibrillation therapy and prevention of sudden cardiac death in the near future.

KW - Defibrillation technology

KW - Subcutaneous ICD

KW - Sudden cardiac death

KW - Ventricular arrhythmias

UR - http://www.scopus.com/inward/record.url?scp=85016405230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016405230&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2017.03.064

DO - 10.1016/j.ijcard.2017.03.064

M3 - Article

VL - 237

SP - 38

EP - 41

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -